SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹22 Cr | ₹-36 Cr | ₹-121 Cr | ₹41 Cr | ₹95 Cr |
What is the latest Consolidated Net Profit of SEQUENT SCIENTIFIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹-36 Cr |
| Mar2023 | ₹-121 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹95 Cr |
How is Consolidated Net Profit of SEQUENT SCIENTIFIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | Positive | |
| Mar2024 | ₹-36 Cr | Negative | |
| Mar2023 | ₹-121 Cr | Negative | |
| Mar2022 | ₹41 Cr | -57.09 | |
| Mar2021 | ₹95 Cr | - | |
Compare Consolidated Net Profit of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹8,941.2 Cr | -2% | 11.7% | 36% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -2% |
11.7% |
36% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses